Search research articles
Contact Us
Filters
Showing results (21-30 of 126) with videos related to
Page
of 13
Sort By:
Epilepsia
|
January 1, 1997
Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality
G A Baker, L Nashef, B A van Hout
Bailliere'S Clinical Gastroenterology
|
September 1, 1994
Assessing the benefits of transplant services
B C Michel, B A Van Hout, G J Bonsel
Heart (British Cardiac Society)
|
August 18, 2004
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)
P W Serruys, P A Lemos, B A van Hout, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 18, 1998
[Guidelines and costs]
A F Casparie, B A van Hout, M L Simoons
Pharmacoeconomics
|
January 19, 2006
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany
Gerd Laux, Bart Heeg, Ben A van Hout, et al.
Health Economics
|
January 29, 2005
Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty
Maiwenn J Al, Talitha L Feenstra, Ben A van Hout
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]
B A Van Hout, F F Rutten, R H Lorijn
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
January 1, 1996
[The development and learning]
P Evrard, P Gressens, S Marret, et al.
Pharmacoeconomics
|
January 19, 2006
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
P S Chue, Bart Heeg, Erik Buskens, et al.
The Journal of Cardiovascular Surgery
|
March 31, 2006
The use of a surgical sealant (CoSeal) in cardiac and vascular reconstructive surgery: an economic analysis
E Buskens, M J Meijboom, H Kooijman, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 126) with videos related to
Sort By:
Page
of 13
Epilepsia
|
January 1, 1997
Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality
G A Baker, L Nashef, B A van Hout
Bailliere'S Clinical Gastroenterology
|
September 1, 1994
Assessing the benefits of transplant services
B C Michel, B A Van Hout, G J Bonsel
Heart (British Cardiac Society)
|
August 18, 2004
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)
P W Serruys, P A Lemos, B A van Hout, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 18, 1998
[Guidelines and costs]
A F Casparie, B A van Hout, M L Simoons
Pharmacoeconomics
|
January 19, 2006
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany
Gerd Laux, Bart Heeg, Ben A van Hout, et al.
Health Economics
|
January 29, 2005
Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty
Maiwenn J Al, Talitha L Feenstra, Ben A van Hout
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]
B A Van Hout, F F Rutten, R H Lorijn
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
January 1, 1996
[The development and learning]
P Evrard, P Gressens, S Marret, et al.
Pharmacoeconomics
|
January 19, 2006
Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada
P S Chue, Bart Heeg, Erik Buskens, et al.
The Journal of Cardiovascular Surgery
|
March 31, 2006
The use of a surgical sealant (CoSeal) in cardiac and vascular reconstructive surgery: an economic analysis
E Buskens, M J Meijboom, H Kooijman, et al.
Page
of 13